NewLimit Reports Best Age-Reprogramming Payloads Yet, 5X Gains From Its Reprogramming AI
jacobkimmel · x · 2026-10-22
NewLimit, the cell-reprogramming longevity company, shared its summer progress, calling it the most exciting time in its history and inviting new hires:
- >2X increase in regenerative restoration in old hepatocytes.
- 8 new payloads restoring endothelial function, 5 in hepatocytes.
- Therapeutic manufacturing scaled up >300X (LNP-RNA output climbing from 1X in 2024 to 314X) with 13X quality improvement.
- 5X sample-efficiency gains for its reprogramming AI.
Charts also show year-over-year gains in functional composite, metabolic resilience, and mouse/human regeneration metrics through 2026.
More from Companies & People
- How Codex Happened: Inside OpenAI's comeback in AI coding, from failed launch to ChatGPT's centerpiece — every · 2026-10-22
- Stanford HAI Marks 7 Years Since 2019 Launch Across All Seven Schools — StanfordHAI · 2026-10-22
- Analyst predicts $8-10B Skydance-SpaceX deal to fuel Grok Imagine's AI films — beffjezos · 2026-10-22
- Kelsey Tuoc: Living Under Annihilation's Shadow Harms People, Even If They're Right — EigenGender · 2026-10-22
- OpenAI's GPT 6.1 models are coming to Google Cloud and Antigravity — Ars Technica AI · 2026-10-22
- Math Academy's accredited sequence takes adults from arithmetic to ML-level mathematics — AlexKontorovich · 2026-10-22